previous compound ID: 165 next compound
InChIKey: AQCHWTWZEMGIFD-UHFFFAOYSA-N
SMILES: CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "J Liao" "JW Hanrahan" "DY Thomas" "E Matthes" "SD Macknight" "D Rotin" "GW Carlile" "B Kus" "R Robert"

chemical graph of compound 165





CID is 4170
synonyms found at PubChem are:
metolazone, 17560-51-9, Zaroxolyn, Diulo, Mykrox, Microx, Metalozone, Metenix, Oldren, Metolazona, Metolazonum, 7-Chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquinazoline-6-sulfonamide, Metolazonum [INN-Latin], Metolazona [INN-Spanish], Metalazone, Xuret, 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide, Metolazone (Zaroxolyn), SR 720-22, SR-720-22, Zaroxolyn (TN), HSDB 3367, 2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone, Metolazone [USAN:BAN:INN:JAN], 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide, EINECS 241-539-3, UNII-NM7V2Y3G0U, BRN 0965506, NM7V2Y3G0U, Metolazone (JAN/USP/INN), 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-, UNII-NN9U607695, CHEBI:64354, AQCHWTWZEMGIFD-UHFFFAOYSA-N, 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-, 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide, NN9U607695, NCGC00093985-07, 6-Quinazolinesulfonamide, 1,2,3,4-tetrahydro-7-chloro-2-methyl-4-oxo-3-o-tolyl-, 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide, DSSTox_CID_25167, DSSTox_RID_80717, DSSTox_GSID_45167, Q-201399, SMR001230730, SR-05000001765, metozalone, Metolazon, Prestwick_333, CAS-17560-51-9, metolazone (product), Mykrox (TN), Metolazone(Zaroxolyn), Metolazone, (+)-, Metolazone, (-)-, Metolazone [USAN:USP:INN:BAN:JAN], SR72022, Metolazone(Zaroxolyn)/, Spectrum_000456, AC1L1HKJ, Prestwick0_000112, Prestwick1_000112, Prestwick2_000112, Prestwick3_000112, Spectrum2_001741, Spectrum4_000229, Spectrum5_001237, CHEMBL878, D01WLC, (non-labelled)Metolazone-d7, SCHEMBL40558, BSPBio_000124, BSPBio_002422, KBioGR_000897, KBioSS_000936, 5-25-09-00212 (Beilstein Handbook Reference), MLS002153316, MLS002154200, DivK1c_000275, SPECTRUM2300325, SPBio_001842, SPBio_002063, BPBio1_000138, GTPL4838, DTXSID6045167, Mykrox;Zaroxolyn;Diulo;Zaroxolyn, BDBM25899, CTK8B4741, HMS500N17, KBio1_000275, KBio2_000936, KBio2_003504, KBio2_006072, KS-00000ZJQ, MolPort-003-666-780, NINDS_000275, BCPP000166, HMS1568G06, HMS1922L16, HMS2093P14, HMS2095G06, HMS2230J15, HMS3261J22, HMS3373C11, HMS3655M09, HMS3712G06, Pharmakon1600-02300325, BCP21574, EBD54305, HY-B0209, Tox21_110186, Tox21_113526, Tox21_500610, ABP000634, ANW-46001, CCG-39450, MFCD00069304, NSC759581, s1610, Mykrox, Zaroxolyn, Diulo, Metolazone, AKOS015897109, Metolazone, >=98% (HPLC), solid, Tox21_110186_1, API0003352, BCP9000920, CS-2150, DB00524, KS-5139, LP00610, NSC-759581, IDI1_000275, NCGC00093985-01, NCGC00093985-02, NCGC00093985-03, NCGC00093985-04, NCGC00093985-05, NCGC00093985-06, NCGC00093985-08, NCGC00093985-10, NCGC00093985-11, NCGC00261295-01, 4CA-0814, AN-11710, AS-13016, CC-30932, H024, SBI-0051460.P002, AB0012835, AB2000160, AX8140044, KB-249688, LS-140226, TC-134746, AB00052055, FT-0628932, ST24029920, D00431, 7-chloro-2-methyl-4-oxo-3-o-tolyl-1,2,3,4, AB00052055-08, AB00052055_09, AB00052055_10, 560M519, C-21013, SR-05000001765-1, SR-05000001765-4, SR-05000001765-7, BRD-A61793559-001-05-7, BRD-A61793559-001-08-1, Metolazone, European Pharmacopoeia (EP) Reference Standard, Metolazone, United States Pharmacopeia (USP) Reference Standard, 7-chloro-2-methyl-3-(o-tolyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide, 7-Chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydro-6-quinazolinesulfonamide #, 7-Chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquizoline-6-sulfomide, Metolazone for system suitability, European Pharmacopoeia (EP) Reference Standard, 56436-31-8, 56436-32-9, 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-, (+)-, 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-, (-)-